References
- Haddock BT, Francis ST, Larsson HBW, et al. Assessment of perfusion and oxygenation of the human renal cortex and medulla by quantitative MRI during handgrip exercise. J Am Soc Nephrol. 2018;29(10):1–14. doi: 10.1681/asn.2018030272.
- Michel CC. Renal medullary microcirculation: architecture and exchange. Microcirculation. 1995;2(2):125–139. doi: 10.3109/10739689509146761.
- Yuan J, Pannabecker TL. Architecture of inner medullary descending and ascending vasa recta: pathways for countercurrent exchange. Am J Physiol Renal Physiol. 2010;299(1):F265–F272. doi: 10.1152/ajprenal.00071.2010.
- Ergin B, Akin S, Ince C. Kidney microcirculation as a target for innovative therapies in AKI. J Clin Med. 2021;10(18):4041. doi: 10.3390/jcm10184041.
- Wallace MA. Anatomy and physiology of the kidney. Aorn J. 1998;68(5):800, 803–820. 803-816, 819-820; quiz 821-804. doi: 10.1016/s0001-2092(06)62377-6.
- Bábíčková J, Klinkhammer BM, Buhl EM, et al. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries. Kidney Int. 2017;91(1):70–85. doi: 10.1016/j.kint.2016.07.038.
- Cankurtaran V, Inanc M, Tekin K, et al. Retinal microcirculation in predicting diabetic nephropathy in type 2 diabetic patients without retinopathy. Ophthalmologica. 2020;243(4):271–279. doi: 10.1159/000504943.
- Ninkov A, Frank JR, Maggio LA. Bibliometrics: methods for studying academic publishing. Perspect Med Educ. 2022;11(3):173–176. doi: 10.1007/s40037-021-00695-4.
- Sabe M, Pillinger T, Kaiser S, et al. Half a century of research on antipsychotics and schizophrenia: a scientometric study of hotspots, nodes, bursts, and trends. Neurosci Biobehav Rev. 2022;136:104608. doi: 10.1016/j.neubiorev.2022.104608.
- Liang C, Luo A, Zhong Z. Knowledge mapping of medication literacy study: a visualized analysis using CiteSpace. SAGE Open Med. 2018;6:2050312118800199. doi: 10.1177/2050312118800199.
- Madsen K, Marcussen N, Pedersen M, et al. Angiotensin II promotes development of the renal microcirculation through AT1 receptors. J Am Soc Nephrol. 2010;21(3):448–459. doi: 10.1681/asn.2009010045.
- Shao W, Rosales CB, Gonzalez C, et al. Effects of serelaxin on renal microcirculation in rats under control and high-angiotensin environments. Am J Physiol Renal Physiol. 2018;314(1):F70–F80. doi: 10.1152/ajprenal.00201.2017.
- Takenaka T, Suzuki H, Fujiwara K, et al. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. J Clin Invest. 1997;100(8):2107–2114. doi: 10.1172/jci119745.
- Liu L, Xu J, Zhang Z, et al. Metabolic homeostasis of amino acids and diabetic kidney disease. Nutrients. 2022;15(1):184. doi: 10.3390/nu15010184.
- Nilsson KF, Sandin J, Gustafsson LE, et al. The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure. Intensive Care Med Exp. 2017;5(1):29. doi: 10.1186/s40635-017-0143-4.
- Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423. doi: 10.1007/s00134-015-3934-7.
- Suarez J, Busse LW. New strategies to optimize renal haemodynamics. Curr Opin Crit Care. 2020;26(6):536–542. doi: 10.1097/mcc.0000000000000774.
- Chade AR. Small vessels, big role: renal microcirculation and progression of renal injury. Hypertension. 2017;69(4):551–563. doi: 10.1161/hypertensionaha.116.08319.
- Seifert ME, Gaut JP, Guo B, et al. WNT pathway signaling is associated with microvascular injury and predicts kidney transplant failure. Am J Transplant. 2019;19(10):2833–2845. doi: 10.1111/ajt.15372.
- Li S, Wang F, Sun D. The renal microcirculation in chronic kidney disease: novel diagnostic methods and therapeutic perspectives. Cell Biosci. 2021;11(1):90. doi: 10.1186/s13578-021-00606-4.
- Chen C, Sun L, Zhang W, et al. Limb ischemic preconditioning ameliorates renal microcirculation through activation of PI3K/akt/eNOS signaling pathway after acute kidney injury. Eur J Med Res. 2020;25(1):10. doi: 10.1186/s40001-020-00407-4.
- Yang SJ, Fan CN, Wang MJ, et al. Effects of dexmedetomidine on renal microcirculation in ischemia/reperfusion-induced acute kidney injury in rats. Sci Rep. 2021;11(1):2026. doi: 10.1038/s41598-021-81288-3.
- Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311–322. doi: 10.1056/NEJMoa1603827.
- Wanner C, Inzucchi SE, Lachin JM, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375(4):323–334. doi: 10.1056/NEJMoa1515920.
- Cherney DZ, Perkins BA, Soleymanlou N, et al. Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus. Circulation. 2014;129(5):587–597. doi: 10.1161/circulationaha.113.005081.
- Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295–2306. doi: 10.1056/NEJMoa1811744.
- Kwiatkowska E, Kwiatkowski S, Dziedziejko V, et al. Renal microcirculation injury as the main cause of ischemic acute kidney injury development. Biology (Basel). 2023;12(2):327. doi: 10.3390/biology12020327.
- Mapuskar KA, Pulliam CF, Tomanek-Chalkley A, et al. The antioxidant and anti-inflammatory activities of avasopasem manganese in age-associated, cisplatin-induced renal injury. Redox Biol. 2024;70:103022. doi: 10.1016/j.redox.2023.103022.
- Cortes AL, Gonsalez SR, Rioja LS, et al. Protective outcomes of low-dose doxycycline on renal function of wistar rats subjected to acute ischemia/reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2018;1864(1):102–114. doi: 10.1016/j.bbadis.2017.10.005.
- Nakayama T, Mitsuno R, Azegami T, et al. A systematic review and meta-analysis of the clinical impact of stopping renin-angiotensin system inhibitor in patients with chronic kidney disease. Hypertens Res. 2023;46(6):1525–1535. doi: 10.1038/s41440-023-01260-8.